RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com
  

Glenmark Pharmaceuticals S a patents

Recent patent applications related to Glenmark Pharmaceuticals S a. Glenmark Pharmaceuticals S a is listed as an Agent/Assignee. Note: Glenmark Pharmaceuticals S a may have other listings under different names/spellings. We're not affiliated with Glenmark Pharmaceuticals S a, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Glenmark Pharmaceuticals S a-related inventors




Date Glenmark Pharmaceuticals S a patents (updated weekly) - BOOKMARK this page
05/25/17Production of t cell retargeting hetero-dimeric immunoglobulins
05/18/17Nanoparticulate formulation comprising a mpges-1 inhibitor
01/26/17Aryl and heteroaryl ether compounds as ror gamma modulators
12/01/16Treatment of respiratory disorders using ror-gamma inhibitors
11/24/16Triazolone compounds as mpges-1 inhibitors
11/10/16Bicyclic heteroaryl indole analogues useful as ror gamma modulators
11/03/16Anti-trka antibodies with enhanced inhibitory properties and derivatives thereof
06/09/16Pharmaceutical composition comprising a trpa1 antagonist and a steroid
12/03/15Antibody formulation
10/08/15Triazolone compounds as mpges-1 inhibitors
08/27/15Purification of hetero-dimeric immunoglobulins
07/02/15Anti-trka antibodies with enhanced inhibitory properties and derivatives thereof
06/04/15Thienopyrimidinedione derivatives as trpa1 modulators
05/14/15Production of t cell retargeting hetero-dimeric immunoglobulins
04/23/15Amides of 2-amino-4-arylthiazole compounds and their salts
04/16/15Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent
03/26/15Triazolone compounds as mpges-1 inhibitors
02/26/15Expression constructs and methods for expressing polypeptides in eukaryotic cells
12/25/14Nanoparticulate formulation comprising a trpa1 antagonist
11/20/14Anti-alpha2 integrin antibodies and their uses
10/16/14Antibodies that bind to tl1a and their uses
10/02/14Antibodies that bind to ox40 and their uses
09/25/14Humanized antibodies that bind to cd19 and their uses
07/03/14Hetero-dimeric immunoglobulins
05/29/14Pharmaceutical composition comprising a trpa1 antagonist and a steroid
05/08/14Fused pyrimidine-dione derivatives as trpa1 modulators
04/17/14Pharmaceutical composition comprising a trpa1 antagonist and a beta-2 agonist
03/06/14Hetero-dimeric immunoglobulins
02/20/142-amino-4-arylthiazole compounds as trpa1 antagonists
02/13/142-amino-4-arylthiazole compounds as trpa1 antagonists
12/26/13Expression cassette
08/15/13Bicyclic compounds as mpges-1 inhibitors
08/08/13Pharmaceutical composition comprising a pyrimidineone derivative
07/18/13Antibodies that bind to ox40 and their uses
04/04/13Treatment with anti-alpha2 integrin antibodies
12/13/12Treatment of respiratory disorders using trpa1 antagonists
11/22/12Thienopyrimidinedione derivatives as trpa1 modulators
11/01/12Substituted benzofused derivatives and their use as vanilloid receptor ligands
06/21/122-amino-4-arylthiazole compounds as trpai antagonists
06/07/12Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
05/10/12Fused pyrimidineone compounds as trpv3 modulators
05/03/12Tricyclic compounds as mpges-1 inhibitors
05/03/12Fused pyrimidineone compounds as trpv3 modulators
02/16/12Substituted benzofused derivatives and their use as vanilloid receptor ligands
01/12/12Isothiazolo-pyrimidinedione derivatives as trpai modulators
10/20/11Fused imidazole derivatives as trpv3 antagonist
09/29/11Chromenone derivatives as trpv3 antagonists
08/04/11Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
07/28/11Tissue selective stearoyl-coa desaturase 1 inhibitors and cell based screening assay for their identification
06/30/11Pharmaceutical compositions for the treatment of inflammatory and allergic disorders
06/09/11Anti-alpha2 integrin antibodies and their uses
04/28/11Chromane derivatives as trpv3 modulators
01/27/11Substituted benzofused derivatives and their use as vanilloid receptor ligands
11/18/10Fused pyrimidine derivatives as trpv3 modulators
08/26/10Humanized antibodies that bind to cd19 and their uses
07/08/10Pharmaceutical composition that includes a dipeptidyl peptidase-iv inhibitor
07/01/10Novel processes for preparing 6-(difluoromethoxy)[1]benzofuro[3,2-c]pyridine-9-carbaldehyde, a novel intermediate for the synthesis of pde iv inhibitors
06/24/10Treatment with anti-alpha2 integrin antibodies
06/17/10Fused imidazole carboxamides as trpv3 modulators
12/31/09Quinazolinedione derivatives as trpa1 modulators
12/17/09Cannabinoid receptor modulators for treating non-immediate type allergic diseases
12/10/09Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
11/19/09Fused pyrimidineone compounds as trpv3 modulators
11/12/09Process for the preparation of n-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide
09/17/09Humanized antibodies specific for von willebrand factor
Patent Packs
07/16/09Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Glenmark Pharmaceuticals S a in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Glenmark Pharmaceuticals S a with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';